Redmile Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Redmile Group’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,630	Closed	-$296K	–	82
2019 Q3	$296K	Hold	21,630	–	–	0.01%	65
2019 Q2	$266K	Hold	21,630	–	–	0.01%	74
2019 Q1	$270K	Buy	21,630 +8,370	+63%	+$112K	0.01%	73
2018 Q4	$150K	Hold	13,260	–	–	0.01%	73
2018 Q3	$248K	Hold	13,260	–	–	0.01%	79
2018 Q2	$343K	Buy	13,260 +3,330	+34%	+$86.4K	0.01%	72
2018 Q1	$223K	Buy	+9,930	New	+$242K	0.01%	62
2015 Q3	–	Sell	-142,483	Closed	-$3.12M	–	70
2015 Q2	$3.12M	Sell	142,483 -47,141	-25%	-$951K	0.26%	49
2015 Q1	$4.27M	Sell	189,624 -125,520	-40%	-$2.91M	0.38%	46
2014 Q4	$6.36M	Sell	315,144 -150,789	-32%	-$2.73M	0.69%	40
2014 Q3	$8.51M	Sell	465,933 -38,150	-8%	-$552K	0.98%	40
2014 Q2	$6.79M	Buy	504,083 +10,900	+2%	+$149K	0.82%	39
2014 Q1	$8.11M	Buy	+493,183	New	+$8.53M	0.97%	37

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Redmile Group's FLXN Position: Q4 2019 in Review

Redmile Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 21,630 shares — an estimated $296K sold.

Redmile Group first reported a position in FLXN in Q1 2014 and held it in 13 quarters. The position peaked at $8.51M in Q3 2014. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

Redmile Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
Redmile Group sold 21,630 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $296K.
Redmile Group first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 13 quarters.
Redmile Group's Flexion Therapeutics, Inc. position peaked at $8.51M in Q3 2014.
133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Redmile Group's 13F filing for Q4 2019, filed 14 Feb 2020.